Bibert, Stéphanie; Guex, Nicolas; Lourenco, Joao; Brahier, Thomas; Papadimitriou-Olivgeris, Matthaios; Damonti, Lauro; Manuel, Oriol; Liechti, Robin; Götz, Lou; Tschopp, Jonathan; Quinodoz, Mathieu; Vollenweider, Peter; Pagani, Jean-Luc; Oddo, Mauro; Hügli, Olivier; Lamoth, Frédéric; Erard, Véronique; Voide, Cathy; Delorenzi, Mauro; Rufer, Nathalie; ... (2021). Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Frontiers in immunology, 12, p. 666163. Frontiers Research Foundation 10.3389/fimmu.2021.666163
|
Text
fimmu-12-666163.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (11MB) | Preview |
The reason why most individuals with COVID-19 have relatively limited symptoms while other develop respiratory distress with life-threatening complications remains unknown. Increasing evidence suggests that COVID-19 associated adverse outcomes mainly rely on dysregulated immunity. Here, we compared transcriptomic profiles of blood cells from 103 patients with different severity levels of COVID-19 with that of 27 healthy and 22 influenza-infected individuals. Data provided a complete overview of SARS-CoV-2-induced immune signature, including a dramatic defect in IFN responses, a reduction of toxicity-related molecules in NK cells, an increased degranulation of neutrophils, a dysregulation of T cells, a dramatic increase in B cell function and immunoglobulin production, as well as an important over-expression of genes involved in metabolism and cell cycle in patients infected with SARS-CoV-2 compared to those infected with influenza viruses. These features also differed according to COVID-19 severity. Overall and specific gene expression patterns across groups can be visualized on an interactive website (https://bix.unil.ch/covid/). Collectively, these transcriptomic host responses to SARS-CoV-2 infection are discussed in the context of current studies, thereby improving our understanding of COVID-19 pathogenesis and shaping the severity level of COVID-19.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology |
UniBE Contributor: |
Damonti, Lauro (B) |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1664-3224 |
Publisher: |
Frontiers Research Foundation |
Language: |
English |
Submitter: |
Annelies Luginbühl |
Date Deposited: |
16 Dec 2021 10:58 |
Last Modified: |
29 Mar 2023 23:38 |
Publisher DOI: |
10.3389/fimmu.2021.666163 |
PubMed ID: |
34135895 |
Uncontrolled Keywords: |
COVID-19 RNA-sequencing SARS-CoV-2 immune profiling influenza whole blood transcriptome |
BORIS DOI: |
10.48350/161982 |
URI: |
https://boris.unibe.ch/id/eprint/161982 |